Trials / Conditions / Hemophagocytic Lymphohistiocytoses

Hemophagocytic Lymphohistiocytoses

21 registered clinical trials studyying Hemophagocytic Lymphohistiocytoses — 11 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH) NCT06160791	Jerry Lee, MD, MSc, MPhil	Phase 2
Not Yet Recruiting	Modified DEP Regimens for the Treatment of Hemophagocytic Lymphohistiocytosis NCT06504030	The First Affiliated Hospital of Soochow University	Phase 4
Not Yet Recruiting	A Study on Efficacy and Safety of iNK Cells for CAEBV /EBV-HLH After Allo-HSCT NCT06491719	Beijing Friendship Hospital	N/A
Recruiting	Flow Cytometry for the Study of T-Cell Populations in Hemophagocytic Lymphohistiocytosis Associated With Lymph NCT06585124	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	—
Active Not Recruiting	Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion NCT05236764	Baylor College of Medicine	N/A
Not Yet Recruiting	Efficacy and Safety of Carrimycin Tablets in HLH Patients With Carbapenem-resistant Infections NCT05988177	Beijing Friendship Hospital	N/A
Recruiting	Describing Treatment Outcomes and Responses in Lymphoma-associated Hemophagocytic Lymphohistiocytosis NCT05898477	University of Alabama at Birmingham	—
Completed	A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetic Characteristics, and Immunogenicity of NCT07034209	TJ Biopharma Co., Ltd.	Phase 2
Unknown	Response Prediction in EBV-HLH Using Metabonomics Analysis NCT05677178	Beijing Friendship Hospital	—
Completed	HLH Patients - a Retrospective Study NCT05531721	Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna	—
Unknown	Sensitivity and Specificity of Cytokines in the Diagnosis of Lymphoma-associated HLH NCT05600959	Beijing Friendship Hospital	—
Unknown	Cytokine Guided Risk Stratification and Treatment in Pediatric Hemophagocytic Lymphohistiocytosis NCT05491304	The Children's Hospital of Zhejiang University School of Medicine	Phase 4
Recruiting	CytOSorb TreatMent Of Critically Ill PatientS Registry NCT05146336	CytoSorbents, Inc	—
Recruiting	INTO-HLH: A Disease Registry for Patients With Hemophagocytic Lymphohistiocytosis (HLH) NCT05277272	Children's Hospital Medical Center, Cincinnati	—
Recruiting	Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflamma NCT04902807	Institut National de la Santé Et de la Recherche Médicale, France	—
Recruiting	Prospective Validation of the OHI Index NCT05882175	Meir Medical Center	—
Terminated	A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients With HLH NCT03985423	Swedish Orphan Biovitrum	Phase 2 / Phase 3
Completed	Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation NCT03513328	University of Florida	Phase 1 / Phase 2
Completed	Early Detection of Epstein-Barr Virus Related Disease. NCT03546101	University of Aarhus	—
Recruiting	Prospective Cohort for Adult Hemophagocytosis NCT03117010	Samsung Medical Center	—
Completed	Evaluation of IFNγ and Inflammatory Mediators in Patients With Hemophagocytic Lymphohistiocytosis NCT06047210	Swedish Orphan Biovitrum	—